Skip to main content
Tuesday, November 17, 2026Nov 17

Biden’s Medicare price negotiation push is broadly popular. But he’s not getting much credit

FILE - President Joe Biden speaks about his administration's plans to protect Social Security and Medicare and lower healthcare costs, Thursday, Feb. 9, 2023, at the University of Tampa in Tampa, Fla. Biden is trumpeting Medicare’s new powers to negotiate directly with drugmakers on the cost of prescription medications, but a new poll from The Associated Press-NORC Center for Public Affairs Research shows that any immediate political boost that Biden gets may be limited. (AP Photo/Patrick Semansky, File)
FILE - President Joe Biden speaks about his administration's plans to protect Social Security and Medicare and lower healthcare costs, Thursday, Feb. 9, 2023, at the University of Tampa in Tampa, Fla. Biden is trumpeting Medicare’s new powers to negotiate directly with drugmakers on the cost of prescription medications, but a new poll from The Associated Press-NORC Center for Public Affairs Research shows that any immediate political boost that Biden gets may be limited. (AP Photo/Patrick Semansky, File)

WASHINGTON (AP) — President Joe Biden is trumpeting Medicare’s new powers to negotiate directly with drugmakers on the cost of prescription medications — but a poll shows that any immediate political boost that Biden gets for enacting the overwhelmingly popular policy may be limited.

Three-quarters of Americans, or 76%, favor allowing the federal health care program for the elderly to negotiate prices for certain prescription drugs. That includes strong majorities of Democrats (86%) and Republicans (66%), according to a new poll from The Associated Press-NORC Center for Public Affairs Research. About one in five Americans are neutral on the issue, while 6% outright oppose it.

But the poll shows Biden’s approval rating, at 40%, is about where it’s been for the last year. Americans are split on how the Democratic president is handling the issue of prescription drug prices — 48% approve, making it a relative strong point for him, but 50% disapprove.

Seven in 10 Democrats approve of how Biden is handling the issue of prescription drug prices, compared to about a third of independents and about a quarter of Republicans. Even so, Republicans are still much more likely to approve of how Biden is handling prescription drug prices than they are to approve of his job efforts overall (8%).

Even among the Americans who support allowing Medicare to negotiate drug prices, approval of Biden’s handling of the issue remains relatively tepid. A slim majority (55%) approve, but 43% disapprove.